IP Library Granted Patent US 10,028,689
Granted Patent B2
US 10,028,689 · App. 15/832,087 · Granted Jul 24, 2018

Systems and methods for parenterally procuring bodily-fluid samples with reduced contamination

Inventor: Richard G. Patton (Seattle, WA)
Assignee: Magnolia Medical Technologies, Inc.
A61B5/150221A61B5/150099A61B5/150251A61B5/150343A61B5/150977A61B5/150992B01L3/502B01L2200/026B01L2200/141B01L2300/0672B01L2400/082
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,028,689
App. No.
15/832,087
Granted
Jul 24, 2018
Kind
B2
Abstract

The present invention is directed to the parenteral procurement of bodily-fluid samples. The present invention is also directed to systems and methods for parenterally procuring bodily-fluid samples with reduced contamination from dermally-residing microbes. In some embodiments, a bodily-fluid withdrawing system is used to withdraw bodily fluid from a patient for incubation in culture media in one or more sample vessels. Prior to withdrawing bodily fluid into the one or more sample vessels for incubation, an initial volume of withdrawn bodily fluid is placed in one or more pre-sample reservoirs and is not used for the incubation in culture media.

Claims (50)

1. An apparatus for obtaining biological fluid samples from a patient, the apparatus comprising:

a needle having a lumen configured for insertion into the patient;

an input tube fluidically coupled to the needle;

a junction having an inlet fluidically coupled to the input tube, a first outlet fluidically coupled to the inlet, and a second outlet fluidically coupled to the inlet;

a contaminant reservoir fluidically coupled to the first outlet of the junction; and

an output tube fluidically coupled to the second outlet of the junction,

the junction operable to allow an initial volume of biological fluid to flow from the patient to the contaminant reservoir, and to transition as a direct result of filling the contaminant reservoir to allow a subsequent volume of biological fluid to flow from the inlet to the second outlet.

2. The apparatus of claim 1 , whereby filling the contaminant reservoir sequesters the initial volume of biological fluid in the contaminant reservoir and reduces contamination in the biological fluid flowing to the output tube.

3. The apparatus of claim 2 , wherein the subsequent volume of biological fluid flowing to the output tube is substantially free of microbial artifacts.

4. The apparatus of claim 1 , wherein the contaminant reservoir is integrated into the apparatus and is configured to receive less than 5 ml of biological fluid.

5. The apparatus of claim 1 , wherein the junction transitions from a first state in which the initial volume of biological fluid can flow to the contaminant reservoir, to a second state in which the subsequent volume of biological fluid can flow to the second outlet.

6. The apparatus of claim 1 , wherein all of the initial volume of the biological fluid from the patient flows into the contaminant reservoir.

7. The apparatus of claim 1 , wherein the initial volume of biological fluid is fluidically isolated in the contaminant reservoir.

8. A biological fluid sequestration apparatus configured to be fluidically coupled to a sample vessel, the biological fluid sequestration apparatus comprising:

an inlet port fluidically coupled to a lumen-containing device; and

a contaminant reservoir and a sampling flow path, each of the contaminant reservoir and the sampling flow path fluidically coupled to the inlet port via a junction,

the contaminant reservoir and the junction being configured to direct a first portion of biological fluid into the contaminant reservoir,

the sampling flow path fluidically coupled to an outlet port, the sampling flow path and the junction being configured to transition without manual intervention as a direct result of filling the contaminant reservoir to allow a second portion of biological fluid to bypass the contaminant reservoir and to be directed into the sampling flow path toward the outlet port, the outlet port being fluidically coupled to the sample vessel.

9. The apparatus of claim 8 , wherein the contaminant reservoir is integrated into the biological fluid sequestration apparatus.

10. The apparatus of claim 8 , whereby filling the contaminant reservoir sequesters the first portion of biological fluid in the contaminant reservoir.

11. The apparatus of claim 8 , whereby sequestering the first portion of biological fluid in the contaminant reservoir reduces contamination in the biological fluid flowing to the sampling flow path.

12. The apparatus of claim 8 , wherein the second portion of biological fluid flowing to the sampling flow path is substantially free of microbial artifacts.

13. The apparatus of claim 8 , wherein the first portion of biological fluid is less than 5 ml.

14. The apparatus of claim 8 , wherein the junction transitions from a first state in which the first portion of biological fluid can flow to the contaminant reservoir, to a second state in which the second portion of biological fluid can flow to the sampling flow path.

15. The apparatus of claim 8 , wherein all of the first portion of the biological fluid from the patient flows into the contaminant reservoir.

16. The apparatus of claim 8 , wherein the first portion of biological fluid is fluidically isolated in the contaminant reservoir.

17. An apparatus for establishing a sampling flow path substantially free of microbial artifacts between a patient and a sample vessel, the apparatus comprising:

an input tube configured to be fluidically coupled to the patient;

an output tube configured to be fluidically coupled to the sample vessel;

a contaminant reservoir fluidically coupled to the input tube and the output tube; and

a junction disposed between the inlet tube and the output tube and fluidically coupled to the input tube, the output tube, and the contaminant reservoir,

the contaminant reservoir and the junction operable in a first state to allow a first portion of biological fluid to flow into the contaminant reservoir,

the contaminant reservoir and the junction operable in a second state to (a) sequester the first portion of biological fluid in the contaminant reservoir, and (b) to allow a second portion of biological fluid to bypass the contaminant reservoir and to flow to the output tube,

the contaminant reservoir and the junction operable to transition to the second state without manual intervention as a direct result of filling the contaminant reservoir.

18. The apparatus of claim 17 , wherein the first portion of biological fluid is less than 5 ml.

19. The apparatus of claim 17 , whereby sequestering the first portion of biological fluid in the contaminant reservoir reduces contamination in the biological fluid flowing to the output tube.

20. The apparatus of claim 17 , whereby sequestering the first portion of biological fluid in the contaminant reservoir establishes the sampling flow path between the patient and the output tube that is substantially free of microbial artifacts.

21. The apparatus of claim 17 , wherein all of the first portion of the biological fluid from the patient flows into the contaminant reservoir.

22. The apparatus of claim 17 , wherein the first portion of biological fluid is fluidically isolated in the contaminant reservoir.

23. An apparatus for obtaining biological fluid samples from a patient, the apparatus comprising:

a needle having a lumen configured for insertion into the patient;

an input tube fluidically coupled to the needle;

a diverter including a reservoir and a junction configured to control fluid flow from the patient, the junction including an inlet fluidically coupled to the input tube, a first outlet fluidically coupled to the reservoir, and a second outlet fluidically coupled to an output tube,

the junction configured to (a) allow an initial volume of biological fluid to flow from the patient towards the first outlet, and (b) transition without manual intervention as a direct result of receiving the initial volume of biological fluid from the patient to allow a subsequent volume of biological fluid to bypass the initial volume of biological fluid sequestered in the reservoir and to flow to the output tube via the second outlet.

24. The apparatus of claim 23 , wherein the initial volume of biological fluid is less than 5 ml.

25. The apparatus of claim 23 , wherein the diverter is configured to transition at the junction from a first state to a second state, the first state operable to allow the initial volume of biological fluid to flow into the reservoir, the second state operable to (a) sequester the initial volume of biological fluid in the reservoir, and (b) establish fluid communication between the needle and the output tube.

26. The apparatus of claim 23 , wherein the diverter is configured to transition from a first state to a second state as a result of filling the reservoir.

27. The apparatus of claim 23 , wherein the reservoir is integrated into the diverter.

28. The apparatus of claim 23 , wherein all of the initial volume of the biological fluid from the patient flows into the reservoir.

29. The apparatus of claim 23 , wherein the initial volume of biological fluid is fluidically isolated in the reservoir.

Assignments (5)
PATENT SECURITY AGREEMENT Recorded Jan 2, 2024
From: MAGNOLIA MEDICAL TECHNOLOGIES, INC.
To: SYMBIOTIC CAPITAL AGENCY LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 066178/0969 →
RELEASE OF SECURITY INTEREST Recorded Jan 31, 2022
From: FISH & RICHARDSON PC
To: MAGNOLIA MEDICAL TECHNOLOGIES, INC
Reel/Frame 058825/0707 →
LIEN Recorded Mar 30, 2021
From: MAGNOLIA MEDICAL TECHNOLOGIES, INC.
To: FISH & RICHARDSON P.C.
Reel/Frame 057204/0676 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 14, 2018
From: PATTON, RICHARD G.
To: MAGNOLIA MEDICAL TECHNOLOGIES, LLC
Reel/Frame 044922/0521 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 14, 2018
From: MAGNOLIA MEDICAL TECHNOLOGIES, LLC
To: MAGNOLIA MEDICAL TECHNOLOGIES, INC.
Reel/Frame 044922/0551 →
Continuity (13)
Continuation 15457082 · Mar 13, 2017
Continuation 15448891 · Mar 3, 2017
Continuation 15435684 · Feb 17, 2017
Continuation 15432310 · Feb 14, 2017
Continuation 15088842 · Apr 1, 2016
Continuation 14498102 · Sep 26, 2014
Continuation 14089267 · Nov 25, 2013
Continuation 13675295 · Nov 13, 2012
Continuation 13458508 · Apr 27, 2012
Division 13335241 · Dec 22, 2011
Continuation 11955635 · Dec 13, 2007
Provisional Application 60870599 · Dec 18, 2006
Related Publication 20180092583A1 · Apr 5, 2018
Cited By (13)
US 12,186,080 US 12,193,816 US 12,290,363 US 12,471,815 US 12,471,816 US 12,478,300 US 12,478,301 US 12,502,109 US 12,551,150 US 12,564,341 US 12,575,772 US 12,576,204 US 12,638,445